A niche oncology CRO with a global reach. We design and implement smart drug development programs across phase I, II and III oncology trials

Nexus Oncology is now part of Ockham. Ockham – a U.S.-based global specialty CRO focused on oncology – provides Nexus with full-service capabilities, enhancing growth and adding more services for our clients. Please contact us today for more information.